Who invested in BlueRock Therapeutics?
BlueRock Therapeutics's investors include Versant Ventures.
Who invested in BlueRock Therapeutics
One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$225Mraised across 1 round since 2016, from 1 source
- Latest round
- Series A, $225MDec 2016
- Investors
- 1
The rounds
- Dec 2016
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about BlueRock Therapeutics
How much has BlueRock Therapeutics raised?
BlueRock Therapeutics has raised $225M across 1 round since 2016.
When did BlueRock Therapeutics last raise?
BlueRock Therapeutics's most recent round was a Series A of $225M in Dec 2016.
What was BlueRock Therapeutics's biggest round?
Its most recent round, $225M in Dec 2016, is also its largest on record.
Who backed BlueRock Therapeutics first?
BlueRock Therapeutics's first round on record, in Dec 2016, was backed by Versant Ventures.
What stage is BlueRock Therapeutics at?
BlueRock Therapeutics's latest named round is a Series A, in Dec 2016.
Companies like BlueRock Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.